Efficacy and safety of cerebral embolic protection systems during transcatheter aortic valve replacement: a review of current clinical findings

References

• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021 Feb 2;77(4):e25-e197.
   Google Scholar
• Winter MP, Bartko P, Hofer F, et al. Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Sci Rep. 2020 Sep 23;10(1):15568.
   PubMed Web of Science ®Google Scholar
• Kapadia S, Agarwal S, Miller DC, et al. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (Placement of Aortic Transcatheter Valves). Circ Cardiovasc Interv. 2016 Sep;9(9). DOI:10.1161/CIRCINTERVENTIONS.115.002981.
   Web of Science ®Google Scholar
• Daniel K, Wolfe CD, Busch MA, et al. What are the social consequences of stroke for working-aged adults? A systematic review. Stroke. 2009 Jun;40(6):e431–40.
   PubMed Web of Science ®Google Scholar
• Lai SM, Studenski S, Duncan PW, et al. Persisting consequences of stroke measured by the stroke impact scale. Stroke. 2002 Jul;33(7):1840–1844.
   PubMed Web of Science ®Google Scholar
• Stolker JM, Spertus JA, Cohen DJ, et al. Rethinking composite end points in clinical trials: insights from patients and trialists. Circulation. 2014 Oct 7;130(15):1254–1261.
   PubMed Web of Science ®Google Scholar
• Huded CP, Tuzcu EM, Krishnaswamy A, et al. Association between transcatheter aortic valve replacement and early postprocedural stroke. JAMA. 2019 Jun 18;321(23):2306–2315.
   PubMed Web of Science ®Google Scholar
• Vlastra W, Jimenez-Quevedo P, Tchétché D, et al. Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke. Circ Cardiovasc Interv. 2019 Mar;12(3):e007546.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Schmermund A, Voigtländer T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012 May 15;8(1):129–138.
   PubMed Web of Science ®Google Scholar
• Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med. 2013 Jan 1;158(1):35–46.
   PubMed Web of Science ®Google Scholar
• Muralidharan A, Thiagarajan K, Van Ham R, et al. Meta-Analysis of perioperative stroke and mortality in transcatheter aortic valve implantation. Am J Cardiol. 2016 Oct 1;118(7):1031–1045.
   PubMed Web of Science ®Google Scholar
• Généreux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012 Jun 19;59(25):2317–2326.
   PubMed Web of Science ®Google Scholar
• Lansky A, Ghare MI, Tchétché D, et al. TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy. EuroIntervention. 2018 Aug 31;14(Ab):Ab53–ab63.
   PubMedGoogle Scholar
• Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017 Jan 31;69(4):367–377.
   PubMed Web of Science ®Google Scholar
• Messé SR, Acker MA, Kasner SE, et al. Stroke after aortic valve surgery: results from a prospective cohort. Circulation. 2014 Jun 3;129(22):2253–2261.
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. J Am Coll Cardiol. 2011 Jan 18;57(3):253–269.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol. 2012 Oct 9;60(15):1438–1454.
   PubMed Web of Science ®Google Scholar
• Bosmans J, Bleiziffer S, Gerckens U, et al. The incidence and predictors of early- and mid-term clinically relevant neurological events after transcatheter aortic valve replacement in real-world patients. J Am Coll Cardiol. 2015 Jul 21;66(3):209–217.
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012 Dec 18;126(25):3041–3053.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010 Feb 23;121(7):870–878.
   PubMed Web of Science ®Google Scholar
• Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv. 2010 Nov;3(11):1126–1132.
   PubMed Web of Science ®Google Scholar
• Ghanem A, Müller A, Nähle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010 Apr 6;55(14):1427–1432.
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Brown D, Pena C, et al. Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI Trial). Am J Cardiol. 2016 Nov 15;118(10):1519–1526.
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the rotterdam scan study. Stroke. 2003 May;34(5):1126–1129.
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Longstreth WT Jr., Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007 Jul;6(7):611–619.
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, Schipper ME, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013 Jun 4;127(22):2194–2201.
   PubMed Web of Science ®Google Scholar
• Demir OM, Iannopollo G, Mangieri A, et al. The role of cerebral embolic protection devices during transcatheter aortic valve replacement. Front Cardiovasc Med. 2018;5:150.
   PubMed Web of Science ®Google Scholar
• Kahlert P, Al-Rashid F, Döttger P, et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012 Sep 4;126(10):1245–1255.
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. 2016 Jul 20;12(4):499–507.
   PubMed Web of Science ®Google Scholar
• Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA. 2016 Aug 9;316(6):592–601.
   PubMed Web of Science ®Google Scholar
• Nazir S, Zafrullah F, Virk HUH, et al. Meta-Analysis of cerebral embolic protection during transcatheter aortic valve replacement. Am J Cardiol. 2021 Jan 15;139:138–139.
   PubMed Web of Science ®Google Scholar
• Megaly M, Sorajja P, Cavalcante JL, et al. Ischemic stroke with cerebral protection system during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020 Sep 28;13(18):2149–2155.
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Alqahtani F, Harris AH, et al. Early experience with cerebral embolic protection during transcatheter aortic valve replacement in the United States. JAMA Intern Med. 2020 May 1;180(5):783–784.
   PubMed Web of Science ®Google Scholar
• Butala NM, Makkar R, Secemsky EA, et al. Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve therapy registry. Circulation. 2021 Jun 8;143(23):2229–2240.
   PubMed Web of Science ®Google Scholar
• Stachon P, Kaier K, Heidt T, et al. The use and outcomes of cerebral protection devices for patients undergoing transfemoral transcatheter aortic valve replacement in clinical practice. JACC Cardiovasc Interv. 2021 Jan 25;14(2):161–168.
   PubMedGoogle Scholar
• Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015 Aug 14;36(31):2070–2078.
   PubMed Web of Science ®Google Scholar
• Nazif TM, Moses J, Sharma R, et al. Randomized evaluation of triguard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II. JACC Cardiovasc Interv. 2021 Mar 8;14(5):515–527.
   PubMed Web of Science ®Google Scholar
• Wendt D, Kleinbongard P, Knipp S, et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation. Ann Thorac Surg. 2015 Aug;100(2):686–691.
   PubMed Web of Science ®Google Scholar
• Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv. 2010 Nov;3(11):1133–1138.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Kahlert P, Neumann FJ, et al. Feasibility and exploratory efficacy evaluation of the embrella embolic deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014 Oct;7(10):1146–1155.
   PubMed Web of Science ®Google Scholar
• Latib A, Mangieri A, Vezzulli P, et al. First-in-Man study evaluating the emblok embolic protection system during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2020 Apr 13;13(7):860–868.
   PubMed Web of Science ®Google Scholar
• Russell S Total embolic protection: the emboliner embolic protection catheter early clinical results from safepass 2. TCT 2019. 2019.
   Google Scholar
• Fanning JP, Walters DL, Platts DG, et al. Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture? Circulation. 2014 Jan 28;129(4):504–515.
   PubMed Web of Science ®Google Scholar
• Giustino G, Mehran R, Veltkamp R, et al. Neurological outcomes with embolic protection devices in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2016 Oct 24;9(20):2124–2133.
   PubMed Web of Science ®Google Scholar
• Pagnesi M, Martino EA, Chiarito M, et al. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and meta-analysis. Int J Cardiol. 2016 Oct 15;221:97–106.
   PubMed Web of Science ®Google Scholar
• Testa L, Latib A, Casenghi M, et al. Cerebral protection during transcatheter aortic valve implantation: an updated systematic review and meta-analysis. J Am Heart Assoc. 2018 May 4;7(10). DOI:10.1161/JAHA.117.008463.
   PubMed Web of Science ®Google Scholar
• Wang N, Phan K. Cerebral protection devices in transcatheter aortic valve replacement: a clinical meta-analysis of randomized controlled trials. J Thorac Dis. 2018 Mar;10(3):1927–1935.
   PubMed Web of Science ®Google Scholar
• Bagur R, Solo K, Alghofaili S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation: systematic review and meta-analysis. Stroke. 2017 May;48(5):1306–1315.
   PubMed Web of Science ®Google Scholar
• Mohananey D, Sankaramangalam K, Kumar A, et al. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: a clinical end-points meta-analysis. Cardiovasc Revasc Med. 2018 Oct;19(7Pt A):785–791.
   PubMedGoogle Scholar
• Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J. 2019 May 1;40(17):1334–1340.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Leon MB, Mehran R, et al. Debris heterogeneity across different valve types captured by a cerebral protection system during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1262–1273.
   PubMed Web of Science ®Google Scholar
• Seeger J, Virmani R, Romero M, et al. Significant differences in debris captured by the sentinel dual-filter cerebral embolic protection during transcatheter aortic valve replacement among different valve types. JACC Cardiovasc Interv. 2018 Sep 10;11(17):1683–1693.
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, El Faquir N, Rahhab Z, et al. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015 Apr 27;8(5):718–724.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Akdag O, Wohlmuth P, et al. Histological findings and predictors of cerebral debris from transcatheter aortic valve replacement: the ALSTER experience. J Am Heart Assoc. 2016 10;5(11): Nov.
   Web of Science ®Google Scholar
• Van Gils L, Kroon H, Daemen J, et al. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018 Mar 1;91(4):790–797.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Schlüter M, Alessandrini H, et al. Histology of debris captured by a cerebral protection system during transcatheter valve-in-valve implantation. Heart. 2016 Oct 1;102(19):1573–1580.
   PubMed Web of Science ®Google Scholar